logo logo
logo

Key Industries

生技醫藥

  • 日期:2020-08-01
生技醫藥

Source: Industrial Development Bureau, MOEA
Last Updated on: 2019/09/30

 

I. Policy Initiatives

In November 2016, Taiwan launched the "biomedical industry innovation promotion program" to build Taiwan as a pivotal center for the biomedical industry in the Asia-Pacific region. The options for foreign companies to consider in locating their operations or collaborating with local companies are briefly described, as follows:

1. National Biotechnology Park​

To help promote the development of translational medicine research, the Innovation Incubation Center has been set up in the Nangang National Biotechnology Park, inside which institutions such as the National Laboratory Animal Center (NLAC), the Development Center for Biotechnology (DCB), and the Taiwan Food and Drug Administration (TFDA) are located. Foreign companies established their operations in this Park will therefore be able to utilize available resources to gain one-stop assistance in areas such as clinical trials, commercialization of R&D results, and obtaining regulatory restrictions information.

2. Hsinchu Biomedical Science Park​

Three major research centers, namely, the "Biomedical Technology and Product Research and Development Center", the "Industry and Incubation Center", and the "Hsinchu Biomedical Science Park Hospital", are located within this park. Foreign companies established their operations here will be able to take advantage of the shared R&D resources provided by these centers and of their proximity with the Hsinchu Science Park. Businesses based in the Park can join hands with the companies in the information and communication industry, clustering in neighboring areas, to engage in biomedical technology basic research and translational medicine research (see Figure 1).